Your browser doesn't support javascript.
loading
Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.
Sun, Zimin; Liu, Huilan; Luo, Chenhui; Geng, Liangquan; Zheng, Changcheng; Tang, Baolin; Zhu, Xiaoyu; Tong, Juan; Wang, Xingbing; Ding, Kaiyang; Wan, Xiang; Zhang, Lei; Yao, Wen; Song, Kaiding; Zhang, Xuhan; Wu, Yue; Yang, Huizhi; Han, Yongsheng; Liu, Xin; Zhu, Weibo; Wu, Jingsheng; Wang, Zuyi.
Afiliação
  • Sun Z; Department of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, China.
  • Liu H; Department of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, China.
  • Luo C; Department of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, China.
  • Geng L; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Zheng C; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Tang B; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Zhu X; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Tong J; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Wang X; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Ding K; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Wan X; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Zhang L; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Yao W; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Song K; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Zhang X; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Wu Y; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Yang H; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Han Y; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Liu X; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Zhu W; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Wu J; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
  • Wang Z; The First Affiliated Hospital of University of Science and Technology of China, Anhui Sheng, China.
Int J Cancer ; 143(3): 699-708, 2018 08 01.
Article em En | MEDLINE | ID: mdl-29473150

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Condicionamento Pré-Transplante / Transplante de Células-Tronco de Sangue do Cordão Umbilical / Soro Antilinfocitário Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hematológicas / Condicionamento Pré-Transplante / Transplante de Células-Tronco de Sangue do Cordão Umbilical / Soro Antilinfocitário Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article